Your browser doesn't support javascript.
loading
SARS-CoV-2 disrupts respiratory vascular barriers by suppressing Claudin-5 expression.
Hashimoto, Rina; Takahashi, Junya; Shirakura, Keisuke; Funatsu, Risa; Kosugi, Kaori; Deguchi, Sayaka; Yamamoto, Masaki; Tsunoda, Yugo; Morita, Maaya; Muraoka, Kosuke; Tanaka, Masato; Kanbara, Tomoaki; Tanaka, Shota; Tamiya, Shigeyuki; Tokunoh, Nagisa; Kawai, Atsushi; Ikawa, Masahito; Ono, Chikako; Tachibana, Keisuke; Kondoh, Masuo; Obana, Masanori; Matsuura, Yoshiharu; Ohsumi, Akihiro; Noda, Takeshi; Yamamoto, Takuya; Yoshioka, Yasuo; Torisawa, Yu-Suke; Date, Hiroshi; Fujio, Yasushi; Nagao, Miki; Takayama, Kazuo; Okada, Yoshiaki.
Afiliação
  • Hashimoto R; Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto 606-8507, Japan.
  • Takahashi J; Graduate School of Pharmaceutical Sciences, Osaka University, Osaka 565-0871, Japan.
  • Shirakura K; Graduate School of Pharmaceutical Sciences, Osaka University, Osaka 565-0871, Japan.
  • Funatsu R; Graduate School of Pharmaceutical Sciences, Osaka University, Osaka 565-0871, Japan.
  • Kosugi K; Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto 606-8507, Japan.
  • Deguchi S; Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto 606-8507, Japan.
  • Yamamoto M; Department of Clinical Laboratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto 606-8303, Japan.
  • Tsunoda Y; Laboratory of Ultrastructural Virology, Institute for Life and Medical Sciences, Kyoto University, Kyoto 606-8507, Japan.
  • Morita M; Laboratory of Ultrastructural Virology, Graduate School of Biostudies, Kyoto University, Kyoto 606-8507, Japan.
  • Muraoka K; Graduate School of Pharmaceutical Sciences, Osaka University, Osaka 565-0871, Japan.
  • Tanaka M; Graduate School of Pharmaceutical Sciences, Osaka University, Osaka 565-0871, Japan.
  • Kanbara T; Graduate School of Pharmaceutical Sciences, Osaka University, Osaka 565-0871, Japan.
  • Tanaka S; Graduate School of Pharmaceutical Sciences, Osaka University, Osaka 565-0871, Japan.
  • Tamiya S; Graduate School of Pharmaceutical Sciences, Osaka University, Osaka 565-0871, Japan.
  • Tokunoh N; Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan.
  • Kawai A; Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan.
  • Ikawa M; BIKEN Center for Innovative Vaccine Research and Development, The Research Foundation for Microbial Diseases of Osaka University, Osaka 565-0871, Japan.
  • Ono C; Graduate School of Pharmaceutical Sciences, Osaka University, Osaka 565-0871, Japan.
  • Tachibana K; Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan.
  • Kondoh M; Graduate School of Pharmaceutical Sciences, Osaka University, Osaka 565-0871, Japan.
  • Obana M; Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan.
  • Matsuura Y; Center for Infectious Disease Education and Research (CiDER), Osaka University, Osaka 565-0871, Japan.
  • Ohsumi A; Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan.
  • Noda T; Center for Infectious Disease Education and Research (CiDER), Osaka University, Osaka 565-0871, Japan.
  • Yamamoto T; Graduate School of Pharmaceutical Sciences, Osaka University, Osaka 565-0871, Japan.
  • Yoshioka Y; Graduate School of Pharmaceutical Sciences, Osaka University, Osaka 565-0871, Japan.
  • Torisawa YS; Graduate School of Pharmaceutical Sciences, Osaka University, Osaka 565-0871, Japan.
  • Date H; Institute for Open and Transdisciplinary Research Initiatives, Osaka University, Osaka 565-0871, Japan.
  • Fujio Y; Global Center for Medical Engineering and Informatics, Osaka University, Osaka 565-0871, Japan.
  • Nagao M; Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan.
  • Takayama K; Center for Infectious Disease Education and Research (CiDER), Osaka University, Osaka 565-0871, Japan.
  • Okada Y; Department of Thoracic Surgery, Kyoto University Hospital, Kyoto 606-8507, Japan.
Sci Adv ; 8(38): eabo6783, 2022 09 23.
Article em En | MEDLINE | ID: mdl-36129989
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Claudina-5 / SARS-CoV-2 / COVID-19 Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Claudina-5 / SARS-CoV-2 / COVID-19 Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article